LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
$4.12 0.03 (0.7335%)
Analysed LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) News Sources
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
30-06-2026
yahoo.com
Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
15-07-2026
yahoo.com
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15-07-2026
yahoo.com
Lifecore Biomedical Signs Three New Customer Agreements
28-07-2026
yahoo.com
Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
29-07-2026
yahoo.com
Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...
05-08-2026
yahoo.com
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
17-08-2026
yahoo.com
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
02-09-2026
yahoo.com
Lifecore Biomedical to Participate at CPHI Global Conference
03-09-2026
yahoo.com
What is the current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is $4.12.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is $0.03.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is 0.7335%.
What is the most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is .
SEC-8K** Filing Available For LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.